SCHEMBL6175539

SCHEMBL6175539

CC(c1ccnc2ccc(N(C)C)cc12)C1(C(C)c2ccnc3ccc(N(C)C)cc23)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.34
POLB P06746 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
IP6K1 Q92551 1/20 0.33
AR P10275 1/20 0.33
KDM4C Q9H3R0 2/20 0.33
ENPP2 Q13822 1/20 0.32
GRM5 P41594 1/20 0.31
GRM1 Q13255 1/20 0.31
PDE2A O00408 1/20 0.31
ACVR1 Q04771 1/20 0.31
OPRL1 P41146 1/20 0.31
KIT P10721 1/20 0.31
PDGFRA P16234 1/20 0.31
KDR P35968 1/20 0.31
CYP3A4 P08684 1/20 0.31
GAA P10253 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
AAK1 Q2M2I8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174465 0.89 MAPK7 (0.39) TRPV1POLBL3MBTL1ARKDM4C
SCHEMBL6177961 0.89 MAPK7 (0.39) TRPV1POLBL3MBTL1ARCYP3A4
SCHEMBL6172700 0.88 TRPV1 (0.46) TRPV1POLBL3MBTL1ARKDM4C
SCHEMBL6176261 0.88 DDR1 (0.38) TRPV1POLBL3MBTL1ARCYP3A4
SCHEMBL6174964 0.88 TRPV1 (0.35) TRPV1POLBL3MBTL1ARKDM4C
SCHEMBL6172720 0.86 IGF1R (0.41) IP6K1AR
SCHEMBL6172509 0.86 TRPV1 (0.36) TRPV1POLBL3MBTL1ARENPP2
SCHEMBL6175751 0.86 AR (0.41) TRPV1POLBL3MBTL1AROPRL1
SCHEMBL6174623 0.85 IGF1R (0.42) IP6K1ARACVR1CYP3A4CYP2C9
SCHEMBL3729343 0.83 MAPK7 (0.42) POLBL3MBTL1ARACVR1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed